Plasmonic MoO3−x nanoparticles incorporated in Prussian blue frameworks exhibit highly efficient dual photothermal/photodynamic therapy. Issue 12 (21st February 2019)

• Record Type: Journal Article
• Authors: Odda, Atheer Hameid; Xu, Youcui; Lin, Jun; Wang, Gang; Ullah, Naseeb; Zeb, Akif; Liang, Kuang; Wen, Long-ping; Xu, An-Wu
• Is Part Of: Journal of materials chemistry. Volume 7:Issue 12(2019)
• Page Start: 2032
• Page End: 2042
• Publication Date: 2019-02-21
• Subjects: Materials -- Periodicals; Chemistry, Analytic -- Periodicals; Biomedical materials -- Research -- Periodicals; 543.0284
• DOI: 10.1039/c8tb03148g
• Languages: English
• ISSNs: 2050-750X

Abstract

Abstract : A novel PB-MoO3− x NC has been developed by fabrication of molybdenum oxide within the framework of PB, to perform highly efficient synergistic PTT/PDT treatment under a single continuous NIR wave laser. Abstract : Development of near infrared (NIR) light-responsive nanomaterials for high performance multimodal phototherapy within a single nanoplatform is still challenging in technology and biomedicine. Herein, a new phototherapeutic nanoagent based on FDA-approved Prussian blue (PB) functionalized oxygen-deficient molybdenum oxide nanoparticles (MoO3− x NPs) is strategically designed and synthesized by a facile one-pot size/morphology-controlled process. The as-prepared PB-MoO3− x nanocomposites (NCs) with a uniform particle size of ∼90 nm and high water dispersibility exhibited strong optical absorption in the first biological window, which is induced by plasmon resonance in an oxygen-deficient MoO3− x semiconductor. More importantly, PB-MoO3− x NCs not only exhibited a high photothermal conversion efficiency of ∼63.7% and photostability but also offered a further approach for the generation of reactive oxygen species (ROS) upon singular NIR light irradiation which significantly improved the therapeutic efficiency of the PB agent. Furthermore, PB-MoO3− x NCs showed a negligible cytotoxic effect in the dark, but an excellent therapeutic effect toward two triple-negative breast cancer (TNBC) cell lines at a low concentration (20 μg mL −1 ) of NCs and a moderate NIR laser power density. Additionally, efficient tumor ablation and metastasis inhibition in a 4T1 TNBC mouse tumor model can also be realized by synergistic photothermal/photodynamic therapy (PTT/PDT) under a single continuous NIR wave laser. Taken together, this study paved the way for the use of a single nanosystem for multifunctional therapy.